NCT00671749View on ClinicalTrials.gov

Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Acne Vulgaris
Interventions
DRUG

adapalene gel, 0.3%

Applied once daily at bedtime

DRUG

clindamycin/benzoyl peroxide gel

Applied once daily in the morning

Trial Locations (4)

40217

Derm Research, P.L.L.C., Louisville

44483

Brodell Medical, Warren

95819

Center for Dermatology and Laser Surgery, Sacramento

97210

Northwest Cutaneous Research Specialists, Portland

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT00671749 - Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris | Biotech Hunter | Biotech Hunter